Clinical Trials Search at Vanderbilt-Ingram Cancer Center

ADVANTAGE-AF - A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects with Persistent Atrial Fibrillation

Disease Sites:

Not Available

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Ellis, Christopher

Participating Institutions:

Vanderbilt University

Open Date:

06-01-2023

Trial Type:

Other

Protocol ID:

CRE-ARR0017

National Clinical Trial ID:

NCT05443594

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available